Jazz Pharmaceuticals PLC (JAZZ)
105.25
-0.21
(-0.20%)
USD |
NASDAQ |
May 31, 16:00
105.31
+0.06
(+0.06%)
After-Hours: 20:00
Jazz Pharmaceuticals Enterprise Value: 10.53B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 31, 2024 | 10.53B |
May 30, 2024 | 10.54B |
May 29, 2024 | 10.46B |
May 28, 2024 | 10.52B |
May 24, 2024 | 10.58B |
May 23, 2024 | 10.44B |
May 22, 2024 | 10.54B |
May 21, 2024 | 10.64B |
May 20, 2024 | 10.74B |
May 17, 2024 | 10.76B |
May 16, 2024 | 10.86B |
May 15, 2024 | 10.81B |
May 14, 2024 | 10.95B |
May 13, 2024 | 11.03B |
May 10, 2024 | 10.80B |
May 09, 2024 | 11.02B |
May 08, 2024 | 10.87B |
May 07, 2024 | 10.90B |
May 06, 2024 | 10.82B |
May 03, 2024 | 10.83B |
May 02, 2024 | 10.78B |
May 01, 2024 | 10.85B |
April 30, 2024 | 10.87B |
April 29, 2024 | 10.90B |
April 26, 2024 | 10.79B |
Date | Value |
---|---|
April 25, 2024 | 10.66B |
April 24, 2024 | 10.72B |
April 23, 2024 | 10.81B |
April 22, 2024 | 10.75B |
April 19, 2024 | 10.82B |
April 18, 2024 | 10.78B |
April 17, 2024 | 10.64B |
April 16, 2024 | 10.76B |
April 15, 2024 | 10.88B |
April 12, 2024 | 10.86B |
April 11, 2024 | 11.05B |
April 10, 2024 | 11.08B |
April 09, 2024 | 11.08B |
April 08, 2024 | 11.15B |
April 05, 2024 | 11.23B |
April 04, 2024 | 11.15B |
April 03, 2024 | 11.26B |
April 02, 2024 | 11.30B |
April 01, 2024 | 11.39B |
March 31, 2024 | 11.48B |
March 28, 2024 | 11.59B |
March 27, 2024 | 11.60B |
March 26, 2024 | 11.44B |
March 25, 2024 | 11.62B |
March 22, 2024 | 11.68B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.455B
Minimum
Mar 23 2020
17.14B
Maximum
Jul 12 2021
11.35B
Average
11.78B
Median
Enterprise Value Benchmarks
Alkermes PLC | 3.505B |
Endo International PLC (DELISTED) | -777.78M |
Medtronic PLC | 123.93B |
Perrigo Co PLC | 7.167B |
Iterum Therapeutics PLC | 26.71M |
Enterprise Value Related Metrics
Net Income (Quarterly) | -14.62M |
Revenue (Quarterly) | 901.98M |
Total Expenses (Quarterly) | 825.78M |
EPS Diluted (Quarterly) | -0.23 |
Gross Profit Margin (Quarterly) | 89.41% |
Profit Margin (Quarterly) | -1.62% |
Earnings Yield | 4.61% |
Operating Earnings Yield | 7.50% |
Normalized Earnings Yield | 4.847 |